Literature DB >> 31520795

Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios.

Xavier Bossuyt1, Jolien Claessens2, Thibaut Belmondo3, Ellen De Langhe4, Rene Westhovens4, Koen Poesen5, Sophie Hüe3, Daniel Blockmans6, Marvin J Fritzler7, Michael Mahler8, Walter Fierz9.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31520795     DOI： 10.1016/j.autrev.2019.102386

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN： 1568-9972            Impact factor:   9.754


× No keyword cloud information.
  4 in total

Review 1.  Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems.

Authors:  Luigi Cinquanta; Nicola Bizzaro; Giampaola Pesce
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

2.  Likelihood Ratio Approach and Clinical Interpretation of Laboratory Tests.

Authors:  Walter Fierz; Xavier Bossuyt
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

Review 3.  Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease.

Authors:  Irina A Pashnina; Irina M Krivolapova; Tamara V Fedotkina; Varvara A Ryabkova; Margarita V Chereshneva; Leonid P Churilov; Valeriy A Chereshnev
Journal:  Antibodies (Basel)       Date:  2021-02-25

4.  Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases.

Authors:  Luis Eduardo C Andrade; Jan Damoiseaux; Diego Vergani; Marvin J Fritzler
Journal:  J Transl Autoimmun       Date:  2022-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.